Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2001, p. 207-211, Vol. 39, No. 1
Laboratory of Environmental Microbiology,
National Public Health Institute,1
Department of Dermatology, Kuopio University
Hospital,6 and Department of Clinical
Microbiology, Kuopio University Hospital,7
Kuopio, and Institute of Biotechnology, University of
Helsinki,2 and Department of Pathology
and Field Research, National Veterinary and Food Research
Institute,3 Helsinki, Finland;
Bacteriological and Virological Laboratory, Careggi
Hospital, Florence, Italy4; and
Laboratoire de Référence des Mycobactéries,
Institut Pasteur, Paris, France5
Received 24 July 2000/Returned for modification 23 August
2000/Accepted 12 October 2000
Chemotaxonomic and genetic properties were determined for
14 mycobacterial isolates identified as members of a newly described species Mycobacterium bohemicum. The isolates recovered
from clinical, veterinary, and environmental sources were compared for
lipid composition, biochemical test results, and sequencing of the 16S ribosomal DNA (rDNA) and the 16S-23S rDNA internal transcribed spacer
(ITS) regions. The isolates had a lipid composition that was
different from those of other known species. Though the isolates formed
a distinct entity, some variations were detected in the features
analyzed. Combined results of the phenotypic and genotypic analyses
were used to group the isolates into three clusters. The major cluster
(cluster A), very homogenous in all respects, comprised the M. bohemicum type strain, nine clinical and veterinary isolates, and
two of the five environmental isolates. Three other environmental
isolates displayed an insertion of 14 nucleotides in the ITS
region; they also differed from cluster A in fatty alcohol composition
and produced a positive result in the Tween 80 hydrolysis test. Among
these three, two isolates were identical (cluster B), but one isolate
(cluster C) had a unique high-performance liquid chromatography
profile, and its gas liquid chromatography profile lacked
2-octadecanol, which was present in all other isolates analyzed. Thus,
sequence variation in the 16S-23S ITS region was associated with
interesting variations in lipid composition. Two of the isolates
analyzed were regarded as potential inducers of human or veterinary
infections. Each of the environmental isolates, all of which were
unrelated to the cases presented, was cultured from the water of a
different stream. Hence, natural waters are potential reservoirs of
M. bohemicum.
In the past few years, species
descriptions of several unclassified mycobacteria have been published,
and more new species will certainly be identified in the future. In
1998, a novel species, Mycobacterium bohemicum, isolated
from a patient with Down's syndrome and tuberculosis, was described by
Reischl and coworkers (11). Only one additional report on
this species has been presented so far (17). Despite its
recent discovery, M. bohemicum seems to be more common than
many of the other newly classified species. From 1989 through 1996, we
isolated unidentifiable mycobacteria from specimens taken from four
human patients and one goat. Isolates shown to be similar by means of
gas liquid chromatography (GLC) analyses of cellular fatty acid and
alcohol composition and biochemical testing (12) were also
detected among environmental isolates grown from water taken from
Finnish streams in 1990 (4). These isolates have recently
been verified as M. bohemicum by partial sequencing of the
16S rRNA gene. In 1999, an additional three clinical isolates were
identified as M. bohemicum.
We describe here the characteristics of Finnish M. bohemicum
isolates originating from clinical, veterinary, and environmental sources, together with some descriptions of the sources of the isolates. Some minor but interesting differences were detected between
the clinical and environmental isolates, and they are also discussed in
this paper.
Case report 1.
An 85-year-old farmer's wife, without an
earlier history of skin disease, was admitted to the department of
dermatology due to a chronic skin disorder of unknown origin. The first
skin lesions had appeared on the dorsal sides of her hands
approximately 1.5 years earlier and soon spread to cover both arms,
legs, and the trunk. The eczema was resistant to the topical treatments
that were given, including corticosteroids. When entering the hospital, she had nummular lesions with localized conglomerations covering most
parts of her skin. Among these lesions, discrete scratched noduli were
observed. Some of the lesions had bluish discoloration. Tentative
clinical diagnoses included eczema nummulare, sarcoidosis, and livedo
reticularis. Biopsy specimens taken for histopathological examinations
in 1989 and 1990 (10) showed ulcerative dermatitis. No
granuloma formation was detected, but two acid-fast bacilli were
discovered in acid-fast staining. A parallel biopsy submitted for
cultivation of mycobacteria grew M. bohemicum (1949/90)
abundantly. Her chest radiography indicated no inflammatory changes
suggestive of mycobacterial infection. The patient soon succumbed to
cerebrovascular disturbances, and no antimycobacterial therapy was
administered. M. bohemicum was regarded as a potential
inducer of her skin disease; however, this possibility remained
unverified owing to the rapid death of the patient.
Case report 2.
A 2-year-old female Rocky Mountain goat, which
had lived its whole life in a zoo, was euthanized due to an acute total
lameness of the right forelimb and severe disability of the right elbow joint. In a postmortem examination at the National Veterinary and Food
Research Institute, Helsinki, Finland, the goat was found to be in a
good bodily condition. There were bruises around the right shoulder,
and the capsule of the right elbow joint was discovered to be ruptured.
Some mesenteric lymph nodes were found to be slightly enlarged, and on
the cut surface of the enlarged areas, several 1- to 4-mm-diameter
grayish foci were detected by the naked eye. Histopathological
stainings verified granulomatous lymphadenitis with numerous acid-fast
bacilli. M. bohemicum grew in culture on
Löwenstein-Jensen medium. It was concluded that the goat had verified mycobacterial mesenteric lymphadenitis due to M. bohemicum at the time of the traumatic disease, which led to its euthanasia.
Bacterial strains.
The clinical isolates of 1989 to 1993 (21910/89, 1949/90, HO365/91, and 926/93) were recovered from sputum
(n = 3) and skin biopsy (n = 1)
specimens. The specimens were processed by conventional procedures and
cultured in egg-based media, and biopsy specimens were also cultured in
liquid media as described in detail earlier (10). More
recent isolates (2267/99, 7981/99, and 3739-2/99) were grown in the
MGIT 960 system (Becton Dickinson Microbiology Systems, Cockeysville,
Md.) as described elsewhere in detail (6). The veterinary
isolate (3448/96) from a specimen taken during the postmortem biopsy of
a mesenterial lymph node of a Rocky Mountain goat (Oreamnos
americanus) at the National Veterinary and Food Research Institute
was grown in Löwenstein-Jensen medium. The environmental isolates
(E170-2, E445, E590, E743, and E744) were recovered in a study of
stream waters, as described in detail by Iivanainen et al.
(4). After the initial identification, the isolates were
stored in 7H9 broth at Lipid analyses.
The isolates were cultured on mycobacteria
7H11 agar supplemented with Middlebrook OADC enrichment (Difco,
Detroit, Mich.) at 30°C (environmental isolates) or 36°C (clinical
isolates). Fatty acid methyl esters were produced by acid methanolysis
(5). Analyses of lipid composition, including fatty acids,
fatty alcohols, and mycolic acid cleavage products, were performed
using a Perkin-Elmer (Norwalk, Conn.) AutoSystem gas chromatograph.
Peaks were identified using a Hewlett-Packard model G1800A gas
chromatograph (Palo Alto, Calif.) equipped with an electron ionization
detector as described in detail elsewhere (12).
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.207-211.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Mycobacterium
bohemicum Isolated from Human, Veterinary, and Environmental
Sources
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
CASE REPORTS
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
80°C. The M. bohemicum reference
strain (DSM 44277T) was kindly provided for the present
study by J. Kaustova (Ostrava, Czech Republic). A German clinical
isolate (2938/96), which was a gift from L. Naumann (Regensburg,
Germany), was also included in the study. The type strain of
Mycobacterium interjectum (ATCC 51457T), a
species easily confused with M. bohemicum, was also included in the analyses.
Biochemical tests. The isolates were tested at 36°C for urease, arylsulfatase (day 10), pyrazinamidase, semiquantitative catalase, nitrate reduction, and Tween 80 hydrolysis as described earlier (12, 13).
16S rDNA and ITS region sequencing. Amplification of the complete 16S rRNA gene and sequencing of the amplified DNA fragments were performed as described previously (7). The internal transcribed spacer (ITS) region between 16S and 23S ribosomal DNAs (rDNAs) was amplified, and the amplification products were sequenced as described in detail earlier (13).
Environmental analyses. Characteristics of the drainage areas and the chemical, physical, and microbiological qualities of the natural water reservoirs from which the environmental M. bohemicum isolates were obtained were analyzed as described in detail earlier (4).
Nucleotide sequence accession numbers. The ITS region sequence of M. bohemicum type strain DSM 44277T and the 16S rDNA ITS region sequences of the isolates E590 and E743 have been submitted to the EMBL with the accession numbers AJ277282, AJ277283, and AJ277284, respectively.
| |
RESULTS |
|---|
|
|
|---|
Lipid analyses.
In GLC analysis, the type strain of M. bohemicum is characterized by the presence of 2-octadecanol
(2-OH-18:0alc), 2-eicosanol (2-OH-20:0ac), 2-methyl-eicosanoic acid
(2-Me-20:0), 2,4-dimethyl-docosanoic acid
(2,4-diMe-22: 0), 2,4,6-trimethyl-docosanoic acid (2,4,6-triMe-22:0), and 2,4,6-trimethyl-tetracosanoic
acid (2,4,6-triMe-24:0) in addition to the fatty acid markers regarded
as typical of mycobacteria (9). This combination of
markers is different from the profiles described for other known
species. All of the isolates analyzed in this study produced highly
similar profiles. However, minor variations were detected, and these
variations made it possible to divide the isolates into three GLC
clusters. All of the clinical isolates, the veterinary isolate, and two
of the five environmental isolates (E445 and E170-2) had a GLC profile
that was identical to that of the type strain (Fig.
1) (cluster A). The three other environmental isolates, which were otherwise similar, lacked
2-eicosanol (2-OH-20:0alc) (cluster B), or 2-eicosanol and
2-octadecanol (2-OH-18:0alc) (cluster C [isolate E590]) (Table
1).
|
|
-,
metoxy-, keto-, and dicarboxy-mycolates in all three of the M. bohemicum isolates analyzed. In further mycolic acid analyses using HPLC, all but 1 of the 12 isolates examined, including the M. bohemicum type strain, had an identical mycolic acid
profile characterized by a major cluster of peaks eluting between 6 and 7 min and a second cluster eluting between 8 and 9.5 min (Fig. 2). One environmental isolate (E590), on
the other hand, was characterized by a unique cluster of peaks between
7.5 and 9 min. Thus, it differed distinctly in its mycolic acid
composition from the other isolates described here (Fig. 2) as well as
from any known species.
|
Biochemical characteristics. The results of biochemical testing are presented in Table 1. All isolates were smooth, bright yellow, and grew at 42°C. They were positive for semiquantitative catalase, and all but one (E744) was also positive for urease. In contrast to the isolates belonging to GLC cluster A, the isolates of cluster B (E743 and E744) and cluster C (E590) hydrolyzed Tween 80.
16S rDNA and ITS region sequencing.
All of the isolates
included in the study had 16S rDNA sequences that were highly similar
to that of the M. bohemicum type strain (GenBank accession
number U84502) (11). Compared to the type strain 16S rDNA
sequence, there were four nucleotide differences detected in isolates
E743 and E744 and three in isolate E590. All other isolates showed
100% similarity. In ITS sequencing, all but three environmental
isolates had an identical ITS sequence, which also was detected in the
M. bohemicum type strain. These three environmental isolates
(i.e., E590, E743, and E744) had an insertion of 14 nucleotides in the
ITS region sequence (Fig. 3). This
insertion was identical in two of the isolates (cluster B) and included
a one-nucleotide difference in the third isolate (E590; cluster C).
|
Environmental reservoirs of M. bohemicum.
The
environmental isolates were detected in water samples from five
different streams. The sampling sites were located in rural areas and
were not downstream of any known source of animal or human
contamination. Three of the sampling sites were clustered on the
western coast of Finland. The area is former sea bottom with acidic
sulfide soils, and the stream waters in this area are characterized by
high levels of anions and cations (e.g., Cl
,
F
, SO42
, Ca, Mg, Na, and K)
(8). The other two sampling sites were located in inland
regions with high peat coverage (60 and 70%). The concentration of
M. bohemicum (100 to 200 CFU/liter) was low compared to the
total concentrations of mycobacteria in these water samples (970 to
5,800 CFU/liter). As indicated by color (250 to 600 mg of Pt/liter) and
chemical oxygen demand (69 to 180 mg of KMnO4/liter), all
five water samples contained a high amount of organic matter. The pH in
the waters ranged from 5.3 to 6.3.
Clinical significance of isolates. The Finnish clinical isolates were recovered from seven patients, and the veterinary isolate was from a Rocky Mountain goat. In five of the patients, only a single isolate was detected in a minimum of three sputum specimens, and it was regarded as clinically insignificant. In a 52-year-old woman, M. bohemicum (21910/89) was isolated from sputum specimens in two consecutive years (1988 and 1989). In 1991 and 1992, she was found to harbor Mycobacterium avium complex in several sputum specimens. The patient has been lost to further follow-up. In one of the seven patients (case 1) and in the goat (case 2), M. bohemicum was isolated from biopsy specimens and was regarded as an inducer of clinical infection.
| |
DISCUSSION |
|---|
|
|
|---|
Published data on M. bohemicum are limited to the original species description and a very recent case report (16, 17). We isolated M. bohemicum from several sources during the 1990s, including clinical, veterinary, and environmental specimens. Although our present data indicate that its recovery from sputum specimens is likely to be insignificant, M. bohemicum should be listed among potential mycobacterial pathogens causing soft tissue infections in humans and animals. The genetic, biochemical, and lipid characteristics of the isolates from different sources, when compared to the published species description, showed minor variations in biochemical test reactivity, lipid composition, and ITS region sequences.
In 16S rDNA sequencing, the isolates were highly similar to the type strain. On the other hand, interesting variations were detected in the environmental isolates in the sequencing of the ITS region. Differences in both the genetic and GLC lipid compositions divided the studied isolates into the same three main entities. Two of the five environmental isolates as well as the clinical and veterinary isolates included in GLC cluster A were similar to the type strain (Table 1). In contrast, differences including a 14-nucleotide insertion were detected in the ITS region of the other three environmental isolates (GLC clusters B and C). Except for this insertion, these environmental isolates differed from the type strain by only 4 to 5 nucleotides within the ITS region. It is interesting that cluster C (isolate E590) differed appreciably from all other isolates also studied in HPLC analysis.
Slowly growing mycobacteria can be identified correctly by means of GLC by using an identification system which recognizes both fatty acid, fatty alcohols, and mycolic acid cleavage products (3, 5). Our results on M. bohemicum verified these earlier experiences. The characteristic markers of M. bohemicum were secondary alcohols (2-OH-18:0alc; 2-OH-20:0alc) and methyl-branched fatty acids (2-Me-20:0; 2,4-diMe-22:0; 2,4,6-triMe-22:0; 2,4,6-triMe-24:0). These branched-chain fatty acids elute after eicosanoic acid (20:0). Thus, M. bohemicum can be identified by GLC only if fatty acids with carbon chain lengths between 20 and 26, derived from mycolic acids, are included in the analysis. The GLC profile of the scotochromogenic M. interjectum closely resembles that of M. bohemicum. However, M. bohemicum lacks the hexacosanoic acid that is present in significant amounts (5.1% of total area) in M. interjectum. Mycobacterium malmoense is another species with branched-chain fatty acids, 2-Me-20:0, 2,4-diMe-22:0, and 2,4,6-triMe-24:0 (5, 12). This slowly growing species is characterized by the presence of a high amount of hexacosanoic acid, and because it is nonpigmented, it can easily be separated from M. bohemicum.
The HPLC profile of M. bohemicum is similar to but not
identical with M. avium complex and Mycobacterium
scrofulaceum, from which it differs by the retention times of the
major peaks (14). In the present study, all but one of the
isolates had identical HPLC profiles. One environmental isolate (E590)
which was found to be highly similar to other isolates by 16S rDNA
sequencing had a completely different HPLC chromatogram. This indicates
that either M. bohemicum is a species characterized by two
different mycolic acid profiles, as already reported to be the case
with Mycobacterium gordonae and M. interjectum
(2, 15), or E590 belongs to a different taxon,
undistinguishable from M. bohemicum on the basis of 16S rDNA
sequencing. In the TLC mycolic acid analysis, M. bohemicum
contained
-, keto-, metoxy-, and dicarboxy-mycolates. This
combination is unknown in any slow-growing mycobacterial species
described, but is found in Mycobacterium komossense
(19).
Variations in biochemical reactivity were detected among the tested isolates, and some of the results obtained also differed from the earlier species description (11). Nowadays, most new species are described on the basis of genetic analyses of a small number of strains, and biochemical data have also been collected from a limited number of strains. Increasing the number of isolates that are analyzed allows detection of natural variations in biochemical properties, as shown here.
M. bohemicum is not common in the Finnish environment. Only five strains of M. bohemicum (0.7%) were recovered among 757 isolates from 53 water samples. These water samples contained medium to high total mycobacterial concentrations. Yet, natural waters, either directly or via water distribution systems, are potential reservoirs of this recently recognized species, as well as of other species detected as colonizers or pathogens in clinical or veterinary samples.
| |
ACKNOWLEDGMENTS |
|---|
This work was partly funded by the Foundation of Finnish Antituberculous Association and The Finnish Cultural Foundation of Northern Savo (P.T.) and Oskar Öflund's Foundation (S.S.).
We express our gratitude to J. Kaustova and L. Naumann for the strains supplied. We also thank M. Viljanen for providing us with one of the early M. bohemicum isolates.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Lab. Environmental Microbiology, National Public Health Institute, P. O. Box 95, FIN-70701 Kuopio, Finland. Phone: 358-17-201375. Fax: 358-17-201155. E-mail: Pirjo.Torkko{at}ktl.fi.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Butler, W. R.,
L. Thibert, and J. O. Kilburn.
1992.
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography.
J. Clin. Microbiol.
30:2698-2704 |
| 2. |
Cage, G. D.
1992.
High-performance liquid chromatography patterns of Mycobacterium gordonae mycolic acids.
J. Clin. Microbiol.
30:2402-2407 |
| 3. |
Chou, S.,
P. Chedore, and S. Kasatiya.
1998.
Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis.
J. Clin. Microbiol.
36:577-579 |
| 4. |
Iivanainen, E. K.,
P. J. Martikainen,
P. K. Väänänen, and M.-L. Katila.
1993.
Environmental factors affecting the occurrence of mycobacteria in brook waters.
Appl. Environ. Microbiol.
59:398-404 |
| 5. | Jantzen, E., T. Tangen, and J. Eng. 1989. Gas chromatography of mycobacterial fatty acids and alcohols: diagnostic applications. APMIS 97:1037-1045[Medline]. |
| 6. |
Katila, M.-L.,
P. Katila, and R. Erkinjuntti-Pekkanen.
2000.
Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems.
J. Clin. Microbiol.
38:960-964 |
| 7. |
Koukila-Kähkölä, P.,
B. Springer,
E. C. Böttger,
L. Paulin,
E. Jantzen, and M.-L. Katila.
1995.
Mycobacterium branderi sp. nov., a new potential human pathogen.
Int. J. Syst. Bacteriol.
45:549-553 |
| 8. | Lahermo, P., P. Väänänen, T. Tarvainen, and R. Salminen. 1996. Geochemical atlas of Finland,
part 3. Environmental geochemistry stream waters and sediments.
Geological Survey of Finland, Espoo, Finland. Geochemical atlas of
Finland, part 3. English abstract.)
|
| 9. |
Luquin, M.,
V. Ausina,
F. López Calahorra,
F. Belda,
M. García Barceló,
C. Celma, and G. Prats.
1991.
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria.
J. Clin. Microbiol.
29:120-130 |
| 10. | Mattila, J. O., M.-L. Katila, and M. Vornanen. 1996. Slowly growing mycobacteria and chronic skin disorders. Clin. Infect. Dis. 23:1043-1048[Medline]. |
| 11. |
Reischl, U.,
S. Emler,
Z. Horak,
J. Kaustova,
R. M. Kroppenstedt,
N. Lehn, and L. Naumann.
1998.
Mycobacterium bohemicum sp. nov., a new slow-growing scotochromogenic mycobacterium.
Int. J. Syst. Bacteriol.
48:1349-1355 |
| 12. |
Torkko, P.,
M. Suutari,
S. Suomalainen,
L. Paulin,
L. Larsson, and M.-L. Katila.
1998.
Separation among species of Mycobacterium terrae complex by lipid analyses: comparison with biochemical tests and 16S rRNA sequencing.
J. Clin. Microbiol.
36:499-505 |
| 13. | Torkko, P., S. Suomalainen, E. Iivanainen, M. Suutari, E. Tortoli, L. Paulin, and M.-L. Katila. 2000. Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov. Int. J. Syst. Evol. Microbiol. 50:283-289[Abstract]. |
| 14. | Tortoli, E., and A. Bartoloni. 1996. High-performance liquid chromatography and identification of mycobacteria. Rev. Med. Microbiol. 7:207-219. |
| 15. | Tortoli, E., P. Kirschner, A. Bartoloni, C. Burrini, V. Manfrin, A. Mantella, M. Scagnelli, C. Scarparo, M. T. Simonetti, and E. C. Böttger. 1996. Isolation of an unusual mycobacterium from an AIDS patient. J. Clin. Microbiol. 34:2316-2319[Abstract]. |
| 16. | Tortoli, E., P. Kirschner, B. Springer, A. Bartoloni, C. Burrini, A. Mantella, M. Scagnelli, C. Scarparo, M. T. Simonetti, and E. C. Böttger. 1997. Cervical lymphadenitis due to an unusual mycobacterium. Eur. Clin. Microbiol. Infect. Dis. 16:308-311[CrossRef][Medline]. |
| 17. | Tortoli, E., A. Bartoloni, V. Manfrin, A. Mantella, C. Scarparo, and E. Böttger. 2000. Cervical lymphadenitis due to Mycobacterium bohemicum. Clin. Infect. Dis. 30:210-211[CrossRef][Medline]. |
| 18. |
Vincent Lévy-Frébault, V., and F. Portaels.
1992.
Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species.
Int. J. Syst. Bacteriol.
42:315-323 |
| 19. | Yassin, A. F., C. Binder, and K. P. Schaal. 1993. Identification of mycobacterial isolates by thin-layer and capillary gas-liquid chromatography under diagnostic routine conditions. Zentbl. Bakteriol. 278:34-48. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»